| pubmed-article:8301416 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8301416 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
| pubmed-article:8301416 | lifeskim:mentions | umls-concept:C0031751 | lld:lifeskim |
| pubmed-article:8301416 | lifeskim:mentions | umls-concept:C0023089 | lld:lifeskim |
| pubmed-article:8301416 | lifeskim:mentions | umls-concept:C0053055 | lld:lifeskim |
| pubmed-article:8301416 | pubmed:issue | 2-3 | lld:pubmed |
| pubmed-article:8301416 | pubmed:dateCreated | 1994-3-8 | lld:pubmed |
| pubmed-article:8301416 | pubmed:abstractText | The effect of 2 ns pulses of 355 nm laser light on aqueous solutions of pazelliptine (PZE) was investigated and biphotonic ionization was observed. The absorption spectrum corresponding to the pazelliptine radical cation (PZE+) and the hydrated electron simultaneously formed in this process was determined. In the absence of oxygen, eaq- reacted with unexcited PZE (k = 1.6 x 10(10) M-1 s-1) to give the pazelliptine radical anion (PZE-). This latter species was identified by separate pulse radiolysis experiments. The radicals cation and anion disappeared by recombination on the millisecond time range. In presence of oxygen, eaq- was scavenged by O2 leading to the formation of the superoxide radical (O2.-) in competition to the formation of the radical PZE.-.PZE+ reacted with O2.- to produce H2O2 (k = 9 x 10(9) M-1 s-1). The spectral analysis revealed that PZE triplet was also formed during the laser pulse. In the absence of oxygen, the triplet-triplet absorption decreased on the microsecond time scale (2k = 1.5 x 10(10) M-1 s-1). In oxygenated solutions, eaq- and the pazelliptine triplet decayed exponentially in the same time range. | lld:pubmed |
| pubmed-article:8301416 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8301416 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8301416 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8301416 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8301416 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8301416 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8301416 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8301416 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8301416 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8301416 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:8301416 | pubmed:issn | 1011-1344 | lld:pubmed |
| pubmed-article:8301416 | pubmed:author | pubmed-author:BisagniEE | lld:pubmed |
| pubmed-article:8301416 | pubmed:author | pubmed-author:FerradiniCC | lld:pubmed |
| pubmed-article:8301416 | pubmed:author | pubmed-author:RivalleCC | lld:pubmed |
| pubmed-article:8301416 | pubmed:author | pubmed-author:Fontaine-Aupa... | lld:pubmed |
| pubmed-article:8301416 | pubmed:author | pubmed-author:HickelBB | lld:pubmed |
| pubmed-article:8301416 | pubmed:author | pubmed-author:Gardes-Albert... | lld:pubmed |
| pubmed-article:8301416 | pubmed:author | pubmed-author:RenaultEE | lld:pubmed |
| pubmed-article:8301416 | pubmed:author | pubmed-author:FrejacquesMM | lld:pubmed |
| pubmed-article:8301416 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8301416 | pubmed:volume | 21 | lld:pubmed |
| pubmed-article:8301416 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8301416 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8301416 | pubmed:pagination | 203-9 | lld:pubmed |
| pubmed-article:8301416 | pubmed:dateRevised | 2007-7-23 | lld:pubmed |
| pubmed-article:8301416 | pubmed:meshHeading | pubmed-meshheading:8301416-... | lld:pubmed |
| pubmed-article:8301416 | pubmed:meshHeading | pubmed-meshheading:8301416-... | lld:pubmed |
| pubmed-article:8301416 | pubmed:meshHeading | pubmed-meshheading:8301416-... | lld:pubmed |
| pubmed-article:8301416 | pubmed:meshHeading | pubmed-meshheading:8301416-... | lld:pubmed |
| pubmed-article:8301416 | pubmed:meshHeading | pubmed-meshheading:8301416-... | lld:pubmed |
| pubmed-article:8301416 | pubmed:meshHeading | pubmed-meshheading:8301416-... | lld:pubmed |
| pubmed-article:8301416 | pubmed:meshHeading | pubmed-meshheading:8301416-... | lld:pubmed |
| pubmed-article:8301416 | pubmed:meshHeading | pubmed-meshheading:8301416-... | lld:pubmed |
| pubmed-article:8301416 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8301416 | pubmed:articleTitle | Two-photon ionisation of the antitumor drug pazelliptine (BD40) by 355 nm laser photolysis. | lld:pubmed |
| pubmed-article:8301416 | pubmed:affiliation | Laboratoire de Photophysique Moléculaire, Université Paris-Sud, France. | lld:pubmed |
| pubmed-article:8301416 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8301416 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
